3D printers could erase a quarter of global trade
Critics of global trade might find something to celebrate in the advent of 3D printing.
IBM buys Sydney innovation consultancy
The multinational has swallowed the shop responsible for CBA's 'Ka-Ching' and Westpac's 'Genie'.
Brandon breaks even in biotech milestone
The first profit cheque for Brandon Capital's investment team is a watershed for Australian life sciences.
'I would have worn less make-up'
The ACTU's first woman secretary is the most high profile since Greg Combet but there is one thing she regrets about that 7.30 interview eight months ago.
Boards need to break bamboo ceiling
What are Australian boards doing to increase the number of directors with experience in Asia?
'My daughters were bullied horrendously'
In his first sit-down interview since leaving politics, former NSW premier Mike Baird reveals the impact his public life had on his family.
The New Yorker's unlikely saviour
Samuel I Newhouse and The New Yorker seemed like a mismatch at first.
'Independent' board didn't save CBA
Allegations CBA abetted money laundering is proof independent directors do not safeguard against poor culture, industry funds claim.
CSIRO banks bowel cancer test royalty
The CSIRO has received its first cheque for co-invention of a test for bowel cancer touted as twice as effective as those used today.
Issue-based activism is the new 'lawfare'
Like Lazarus, the Australasian Centre for Corporate Responsibility is back.
Featured in Leadership
Most Viewed in Leadership
- 1. 3D printers could erase a quarter of global trade by 2060, says ING
- 2. Brandon Capital breaks even in biotech milestone
- 3. Fair Work Ombudsman proves underpaying 457 visa workers unlawful discrimination
- 4. CSIRO banks Clinical Genomics' bowel cancer test royalty
- 5. How to get anyone to talk to you, according to a cold-calling CEO
